Three-dimensional culture models to study glioblastoma — current trends and future perspectives. (December 2021)
- Record Type:
- Journal Article
- Title:
- Three-dimensional culture models to study glioblastoma — current trends and future perspectives. (December 2021)
- Main Title:
- Three-dimensional culture models to study glioblastoma — current trends and future perspectives
- Authors:
- Joseph, Justin V.
Blaavand, Mathilde S.
Daubon, Thomas
Kruyt, Frank AE.
Thomsen, Martin K. - Abstract:
- Abstract: Glioblastoma (GBM) is the most prevalent form of primary malignant brain tumor in adults and remains almost invariably lethal owing to its aggressive and invasive nature. There have only been marginal improvements in its bleak survival rate of 12–15 months over the last four decades. The lack of preclinical models that efficiently recapitulate tumor biology and the tumor microenvironment is also in part responsible for the slow phase of translational GBM research. Emerging three-dimensional (3D) organoids and cell culture systems offer new and innovative possibilities for GBM modelling. These 3D models find their application to engineer the disease, screen drugs, establishing live biobank, and explore personalized therapy. Furthermore, these models can also be genetically modified by using the clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9 technology, which would allow one to study the specific role of key genes associated with gliomagenesis. Establishment of a coculture system with GBM cells to understand its invasive behavior is yet another major application of this model. Despite these merits, the organoid models also have certain limitations, including the absence of immune responses and vascular systems. In recent years, major progress has been made in the development and refinement of 3D models of GBM. In this review, we intend to highlight these recent advances and the potential future implications of this rapidly evolving field,Abstract: Glioblastoma (GBM) is the most prevalent form of primary malignant brain tumor in adults and remains almost invariably lethal owing to its aggressive and invasive nature. There have only been marginal improvements in its bleak survival rate of 12–15 months over the last four decades. The lack of preclinical models that efficiently recapitulate tumor biology and the tumor microenvironment is also in part responsible for the slow phase of translational GBM research. Emerging three-dimensional (3D) organoids and cell culture systems offer new and innovative possibilities for GBM modelling. These 3D models find their application to engineer the disease, screen drugs, establishing live biobank, and explore personalized therapy. Furthermore, these models can also be genetically modified by using the clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9 technology, which would allow one to study the specific role of key genes associated with gliomagenesis. Establishment of a coculture system with GBM cells to understand its invasive behavior is yet another major application of this model. Despite these merits, the organoid models also have certain limitations, including the absence of immune responses and vascular systems. In recent years, major progress has been made in the development and refinement of 3D models of GBM. In this review, we intend to highlight these recent advances and the potential future implications of this rapidly evolving field, which should facilitate a better understanding of GBM biology. … (more)
- Is Part Of:
- Current opinion in pharmacology. Volume 61(2021)
- Journal:
- Current opinion in pharmacology
- Issue:
- Volume 61(2021)
- Issue Display:
- Volume 61, Issue 2021 (2021)
- Year:
- 2021
- Volume:
- 61
- Issue:
- 2021
- Issue Sort Value:
- 2021-0061-2021-0000
- Page Start:
- 91
- Page End:
- 97
- Publication Date:
- 2021-12
- Subjects:
- Glioblastoma -- 3D culture -- Organoid -- CRISPR -- Human pluripotent stem cells (hPSCs)
Pharmacology -- Periodicals
Pharmaceutical Preparations -- Periodicals
Drug Therapy -- Periodicals
Biopharmaceutics -- Periodicals
Pharmacologie -- Périodiques
Pharmacology
Periodicals
615.105 - Journal URLs:
- http://www.sciencedirect.com/science/journal/14714892 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/14714892 ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/14714892 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.coph.2021.08.019 ↗
- Languages:
- English
- ISSNs:
- 1471-4892
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3500.776920
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 20098.xml